Advertisement
ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.
For fiscal 2023, the company now projects adjusted earnings in a range of $2.09 to $2.59 per share on net revenues between $360 million and $385 million, with purified cortrophin gel revenue at $80 million to $90 million.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.62 per share on revenues of $352.49 million for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use
Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
RTTNews
|
465天前
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution
ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.
RTTNews
|
836天前
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets
ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.
RTTNews
|
1163天前
Additional Support Predicted For Indonesia Shares
The Indonesia stock market has moved higher in two consecutive trading days, gathering almost 50 points or 0.6 percent in that span. The Jakarta Composite Index now sits just above the 7,950-point plateau and it may add to its winnings on Friday.
RTTNews
|
15分鐘前
Australian Market Slightly Lower
The Australian stock market is trading slightly lower on Friday, giving up some of the gains in the previous two sessions, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 9,000 mark, with weakness in mining and financial stocks partially offset by gains in energy and technology stocks.
RTTNews
|
24分鐘前
Hong Kong Shares May Stop The Bleeding On Friday
The Hong Kong stock market has finished lower in three straight sessions, tumbling almost 830 points or 3.3 percent along the way. The Hang Seng Index now rests just beneath the 25,000-point plateau although it may find traction on Friday.
RTTNews
|
30分鐘前
Higher Open Called For China Stock Market
The China stock market on Thursday snapped the two-day losing streak in which it had stumbled more than 80 points or 2.1 percent. The Shanghai Composite Index now sits just above the 3,840-point plateau and it's expected to see additional support on Friday.
RTTNews
|
45分鐘前
Rebound Anticipated For Taiwan Stock Market
The Taiwan stock market on Thursday wrote a finish to the three-day winning streak in which it had jumped more than 750 points or 3.1 percent. The Taiwan Stock Exchange now rests just beneath the 24,230-point plateau although it figures to bounce higher again on Friday.
RTTNews
|
1小時15分鐘前
